The global CAR T-cell therapy market is experiencing substantial growth, driven by growing demand for cutting-edge cancer treatment options. This accelerated expansion is fueled by contributing forces such as the approval of CAR T-cell therapies for diverse conditions, advancements in manufacturing technologies, and increasing research and developm